Posted on November 27, 202311/27/23
EVERSANA Builds on Commitment to “Pharmatize” AI with Amazon Web Services, Introduces Transformative Medical & Regulatory Review Solution
Posted on November 20, 202311/20/23
EVERSANA to Use Adobe Firefly for Enterprise in Creative Development & Modular Content Production for Life Sciences Marketing
Posted on November 6, 202311/6/23
EVERSANA INTOUCH Named Global Independent Pharma Agency of the Year by London International Awards
Posted on October 26, 202310/26/23
EVERSANA Earns Great Place to Work Recognition for Fifth Consecutive Year, Now Certified Across Seven Countries
Posted on October 11, 202310/11/23
EVERSANA Expands Global Commercialisation Capabilities and Strengthens Agency Network with Healthware Group Acquisition
Posted on September 19, 20239/19/23
Sy Pretorius, EVERSANA Chief Operating Officer, Named to Prestigious PharmaVoice 100 List for 2023
Posted on September 6, 20239/6/23